ArticleSkeletal radiology2026
Benign metastasizing leiomyoma: a rare case of osseous involvement.
Article in Skeletal radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Benign metastasizing leiomyoma is a rare entity characterized by the metastasis of histologically benign smooth muscle tumors that originate from uterine leiomyomas. Patients are typically women with a history of uterine leiomyomas for which they have undergone operative treatment. Benign metastasizing leiomyoma most frequently involves the lungs but has been described in other locations. Osseous involvement is rare, with less than 20 cases reported in literature, the majority occurring in the spine. The current case is that of a 67-year-old female with a history of breast carcinoma with multiple lytic osseous lesions involving the pelvis and scapula, initially suspected to represent metastatic disease. Following multi-modality imaging workup including radiographs, CT, MRI, and PET/CT, biopsy revealed benign metastasizing leiomyoma. This case illustrates the multimodality imaging appearance of this rare entity. Radiographs and CT typically show well-defined lytic lesion(s) without aggressive periosteal reaction. On MRI, lesions are often T1 and T2 hypointense, with diffuse enhancement following the administration of contrast. Lesions typically display no or mild FDG uptake on PET/CT, however, varying levels of FDG uptake have been reported in literature. Benign metastasizing leiomyoma with osseous involvement is a rare but clinically significant entity that requires a high index of suspicion in women with a history of uterine leiomyomas and new bone lesions. Radiologists should be aware of this entity so that they may include benign metastasizing leiomyoma in the differential diagnosis when appropriate.
Indexed as
Identifiers
42249958What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.